The Comparative Study of Ligation and Histoacryl(R) Injection in Gastric Varix Bleeding.
- Author:
Byung Seok LEE
1
;
Yeum Seok LEE
;
Seon Mun KIM
;
Seung Weon SEO
;
Hyeon Woong YANG
;
Jae Koo SEONG
;
Sang Woo LEE
;
Euyi Hyeog IM
;
Nam Jae KIM
;
Heon Young LEE
Author Information
1. Department of Internal Medicine, Chungnam National University, College of Medicine, Daejeon, Korea.
- Publication Type:Comparative Study ; Original Article
- Keywords:
Gastric varix;
Endoscopic variceal ligation;
Hisroacryl(R) injection
- MeSH:
Cause of Death;
Chest Pain;
Esophageal and Gastric Varices*;
Fever;
Follow-Up Studies;
Hemorrhage*;
Hemostasis;
Humans;
Ligation*;
Mortality;
Survival Rate;
Varicose Veins
- From:Korean Journal of Gastrointestinal Endoscopy
2000;21(5):825-831
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND/AIMS: The variceal bleeding has high rebleeding rate, and mortality rate was higher in gastrix varix. Managements of variceal bleeding were included such as drugs, endoscopic procedures, surgical management and radiological intervention. Recently histoacryl(R) injection method has been introduced. We have compared the effects of the endoscopic ligation and Histoacryl(R) injection therapy (HAI) in patient with gastric variceal bleeding. METHODS: We analyzed the effects of hemostasis, complications, rebleeding rates, and survival rates in gastric varix bleeding of 22 patients with Histoacryl(R) injection therapy and 20 patients with endoscopic ligation therapy, from January 1995 to March 1999. RESULTS: There were no difference in the complication rate between the 2 stretigies (12/14). Most common complication was chest pain in EVL group, but fever was common in HAI group. Also early and post rebleeding rates were not different in both groups. The main cause of death during follow up period was rebleeding in both groups. The survival rates were 65.0% in EVL group and 77.0% in HAI group (p>0.05, duration: 23+/-2, 28+/-4 month), and there was no difference in mortlity rate (p=0.77). CONCLUSIONS: There were no difference in the hemostatic effect, complications, rebleeding rate and survival rate in EVL group and HAI group. However, evaluation of larger numbers of patients and prospective studies were needed to define the effectiveness and complications of these therapies.
